search
Back to results

Dexmedetomidine and Midazolam Nebulization as Sedation During Cesarean Delivery in Pre-eclampsia

Primary Purpose

Procedural Sedation

Status
Recruiting
Phase
Phase 2
Locations
Egypt
Study Type
Interventional
Intervention
Nebulized dexmedetomidine
Nebulized midazolam
Sponsored by
Zagazig University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Procedural Sedation

Eligibility Criteria

21 Years - 38 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Age: 21-38 years old.
  • Mild and moderate preeclampsia parturient.
  • American Society of AnesthesiologistPhysical status II.
  • Body Mass Index (BMI) (25-35kg/m²).
  • Type of operations: elective cesarean section under spinal anesthesia.
  • Written informed consent from the parturient.

Exclusion Criteria:

  • Altered mental state.
  • Women with known history of allergy to study drugs.
  • Women with uncontrolled diabetes mellitus, bleeding, coagulation disorders, advanced hepatic, renal, cardiovascular, respiratory disease and neuropsychiatric disorders.
  • Patients receiving anticonvulsants or antidepressants.
  • Sever preeclampsia, intrauterine growth restriction or fetal compromise.

Sites / Locations

  • Zagazig University, Faculty of medicineRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

nebulized dexmedetomidine

nebulized midazolam

Arm Description

parturient will receive nebulized 3ug/kg dexmedetomidine diluted in normal saline (0.9%) solution till total volume of nebulized solution will become 5 ml and will be nebulized by a standard hospital jet nebulizer via mouthpiece, with a continuous flow of 100% oxygen at 6 L/min. for 15 minutes, and the treatment will be stopped when the nebulizer will be began to sputter.

parturient will receive nebulized 0.2 mg/kg midazolam diluted in normal saline (0.9%) solution till total volume of nebulized solution will become 5 ml and will be nebulized by a standard hospital jet nebulizer via mouthpiece, with a continuous flow of 100% oxygen at 6 L/min. for 15 minutes, and the treatment will be stopped when the nebulizer will be began to sputter.

Outcomes

Primary Outcome Measures

Chane in the level of sedation
Change in the level of sedation will be assessed using Ramasy Sedation Assessment Scale Ramsay Sedation Scale 1= Patient is anxious and agitated or restless, or both 3= Patient responds to commands only 4= Patient exhibits brisk response to light glabellar tap or loud auditory stimulus 5= Patient exhibits a sluggish response to light glabellar tap or loud auditory stimulus 6= Patient exhibits no response

Secondary Outcome Measures

The discharge time from Post Anesthesia Care Unite (PACU) .
The discharge time from Post Anesthesia Care Unite (PACU) in minutes when achieving modified Aldrete Score 9. Modified Aldert Score. Activity, able to move, voluntarily or on command 4 extremities = 2 2 extremities = 1 No = 0 Breathing Able to breathe deeply & cough freely= 2 Dyspnea, shallow or limited breathing =1 Apnea= 0 Consciousness Fully awake = 2 Arousable on calling = 1 Unresponsive = 0 Circulation (BP) ±20% of pre-anesthesia level= 2 20% to 49% of pre-anesthesia level= 1 50% of pre-anesthesia level= 0 SPO2 Maintains SpO2 >92% in ambient air= 2 Maintain SpO2 >90% with O2 = 1 Maintain SpO2 <90% with O2 = 0
Maternal satisfaction with procedure
Maternal satisfaction with procedure using a 5-point numerical rating scale. 0= Extremely dissatisfied Dissatisfied Neutral Satisfied Extremely satisfied
APGAR score
APGAR score at 1 and 5 min after delivery APGAR score (13). Indicator Score 0 Score 1 Score 2 Activity (muscle tone) Limp; no movement Some flexion of arms and legs Active motion Pulse (heart rate) No heart rate Fewer than 100 beats per minute At least 100 beats per minute Grimace (reflex response) No response to airways being suctioned Grimace during suctioning Grimace and pull away, cough, or sneeze during suctioning Appearance (color) The baby's whole body is completely bluish-gray or pale Good color in body with bluish hands or feet Good color all over Respiration (breathing) Not breathing Weak cry; may sound like whimpering, slow or irregular breathing Good, strong cry; normal rate and effort of breathing Total Score: 3 and below require immediate resuscitation 4 to 7 may require resuscitative measures 7 to 10 is considered normal
Heart rate
heart rate in beat/ minute
Mean arterial blood pressure
Mean arterial blood pressure in mmHg
Oxygen saturation
Oxygen saturation by pulse oximetry.

Full Information

First Posted
April 25, 2021
Last Updated
August 31, 2023
Sponsor
Zagazig University
search

1. Study Identification

Unique Protocol Identification Number
NCT04873596
Brief Title
Dexmedetomidine and Midazolam Nebulization as Sedation During Cesarean Delivery in Pre-eclampsia
Official Title
Comparison Between Dexmedetomidine and Midazolam Nebulization as Procedural Sedation During Cesarean Delivery Under Spinal Anesthesia in Pre-eclamptic Parturients
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
May 15, 2021 (Actual)
Primary Completion Date
January 1, 2024 (Anticipated)
Study Completion Date
February 1, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Zagazig University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Null hypothesis: There is no difference between the effects of nebulization of dexmedetomidine and midazolam as procedural sedation during cesarean delivery under spinal Anesthesia in pre-eclamptic parturients Alternative hypothesis: There is difference between the effects of nebulization of dexmedetomidine and midazolam as procedural sedation during cesarean delivery under spinal anesthesia in pre-eclamptic parturients
Detailed Description
Site of study: This study will be carried out in operating theater of obstetrics at Zagazig University Hospitals. Withdrawal Criteria: The woman has the right to withdraw from the study at any time without any negative consequence on their medical or surgical treatment plan. Double -blind randomized clinical trial. All patients will be hospitalized and visited a day before the surgery, full history with physical examination and routine investigation will be done, the nature and complications of the study will be explained in detail to the patient and informed written consent will be obtained from every woman.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Procedural Sedation

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
94 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
nebulized dexmedetomidine
Arm Type
Active Comparator
Arm Description
parturient will receive nebulized 3ug/kg dexmedetomidine diluted in normal saline (0.9%) solution till total volume of nebulized solution will become 5 ml and will be nebulized by a standard hospital jet nebulizer via mouthpiece, with a continuous flow of 100% oxygen at 6 L/min. for 15 minutes, and the treatment will be stopped when the nebulizer will be began to sputter.
Arm Title
nebulized midazolam
Arm Type
Active Comparator
Arm Description
parturient will receive nebulized 0.2 mg/kg midazolam diluted in normal saline (0.9%) solution till total volume of nebulized solution will become 5 ml and will be nebulized by a standard hospital jet nebulizer via mouthpiece, with a continuous flow of 100% oxygen at 6 L/min. for 15 minutes, and the treatment will be stopped when the nebulizer will be began to sputter.
Intervention Type
Drug
Intervention Name(s)
Nebulized dexmedetomidine
Other Intervention Name(s)
precedex
Intervention Description
parturient will receive nebulized 3ug/kg dexmedetomidine.
Intervention Type
Drug
Intervention Name(s)
Nebulized midazolam
Other Intervention Name(s)
Dormicum
Intervention Description
parturient will receive nebulized 0.2 mg/kg midazolam.
Primary Outcome Measure Information:
Title
Chane in the level of sedation
Description
Change in the level of sedation will be assessed using Ramasy Sedation Assessment Scale Ramsay Sedation Scale 1= Patient is anxious and agitated or restless, or both 3= Patient responds to commands only 4= Patient exhibits brisk response to light glabellar tap or loud auditory stimulus 5= Patient exhibits a sluggish response to light glabellar tap or loud auditory stimulus 6= Patient exhibits no response
Time Frame
at 0 minute (immediately after nebulization) , 5 minutes then every 15 minutes intraoperative
Secondary Outcome Measure Information:
Title
The discharge time from Post Anesthesia Care Unite (PACU) .
Description
The discharge time from Post Anesthesia Care Unite (PACU) in minutes when achieving modified Aldrete Score 9. Modified Aldert Score. Activity, able to move, voluntarily or on command 4 extremities = 2 2 extremities = 1 No = 0 Breathing Able to breathe deeply & cough freely= 2 Dyspnea, shallow or limited breathing =1 Apnea= 0 Consciousness Fully awake = 2 Arousable on calling = 1 Unresponsive = 0 Circulation (BP) ±20% of pre-anesthesia level= 2 20% to 49% of pre-anesthesia level= 1 50% of pre-anesthesia level= 0 SPO2 Maintains SpO2 >92% in ambient air= 2 Maintain SpO2 >90% with O2 = 1 Maintain SpO2 <90% with O2 = 0
Time Frame
up to 30 minutes postoperative
Title
Maternal satisfaction with procedure
Description
Maternal satisfaction with procedure using a 5-point numerical rating scale. 0= Extremely dissatisfied Dissatisfied Neutral Satisfied Extremely satisfied
Time Frame
up to 24hour postoperative
Title
APGAR score
Description
APGAR score at 1 and 5 min after delivery APGAR score (13). Indicator Score 0 Score 1 Score 2 Activity (muscle tone) Limp; no movement Some flexion of arms and legs Active motion Pulse (heart rate) No heart rate Fewer than 100 beats per minute At least 100 beats per minute Grimace (reflex response) No response to airways being suctioned Grimace during suctioning Grimace and pull away, cough, or sneeze during suctioning Appearance (color) The baby's whole body is completely bluish-gray or pale Good color in body with bluish hands or feet Good color all over Respiration (breathing) Not breathing Weak cry; may sound like whimpering, slow or irregular breathing Good, strong cry; normal rate and effort of breathing Total Score: 3 and below require immediate resuscitation 4 to 7 may require resuscitative measures 7 to 10 is considered normal
Time Frame
at 1 and 5 min after delivery
Title
Heart rate
Description
heart rate in beat/ minute
Time Frame
Baseline, at 0 minute (after nebulization), 5 minutes then every 10 minutes intraoperative.
Title
Mean arterial blood pressure
Description
Mean arterial blood pressure in mmHg
Time Frame
Baseline, at 0 minute (after nebulization), 5 minutes then every 10 minutes intraoperative.
Title
Oxygen saturation
Description
Oxygen saturation by pulse oximetry.
Time Frame
Baseline, at 0 minute (after nebulization), 5 minutes then every 10 minutes intraoperative.

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
38 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Age: 21-38 years old. Mild and moderate preeclampsia parturient. American Society of AnesthesiologistPhysical status II. Body Mass Index (BMI) (25-35kg/m²). Type of operations: elective cesarean section under spinal anesthesia. Written informed consent from the parturient. Exclusion Criteria: Altered mental state. Women with known history of allergy to study drugs. Women with uncontrolled diabetes mellitus, bleeding, coagulation disorders, advanced hepatic, renal, cardiovascular, respiratory disease and neuropsychiatric disorders. Patients receiving anticonvulsants or antidepressants. Sever preeclampsia, intrauterine growth restriction or fetal compromise.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Alshaimaa Kamel, M.D
Phone
01005593169
Ext
002
Email
AlshaimaaKamel80@yahoo.com
First Name & Middle Initial & Last Name or Official Title & Degree
Dina Abdelhameed Elsadek salem, M.D
Phone
01099333513
Ext
002
Email
dinamagapy@yahoo.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alshaimaa Kamel, M.D
Organizational Affiliation
Zagazig University, Faculty of human medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Zagazig University, Faculty of medicine
City
Zagazig
Country
Egypt
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alshaimaa Kamel, M.D
Phone
01005593169
Ext
002
Email
AlshaimaaKamel80@yahoo.com
First Name & Middle Initial & Last Name & Degree
Alshaimaa Kamel, M.D

12. IPD Sharing Statement

Learn more about this trial

Dexmedetomidine and Midazolam Nebulization as Sedation During Cesarean Delivery in Pre-eclampsia

We'll reach out to this number within 24 hrs